Linked e-resources

Details

Part A: Proteases and Neural Disorders.-Role of Calpain in Immunobiology of Neurodegenerative Diseases.-Calpain Interactions with the Protein Phosphatase Calcineurin in Neurodegeneration.-Involvement of Caspases in Neurodegenaration and Stroke.-Matrix Metalloproteinases in Ischemia-Reperfusion Injury in Brain: Antioxidants as Rescuer.-The Role of Matrix Metalloproteinases in Neurovascular Injury.-The Role of Proteases in Embryonic Neural Crest Cells.-Part B: Proteases and Cancer
Proteases and Cancer Development.-Matrix Metalloproteinase and its Inhibitors in Cancer Progression.-Ubiquitin-Proteosome System in the Hallmarks of Cancer.-Matrix Metalloproteinases in Cancer Metastasis: An unsolved Mystery.-A Disintegrin and Metalloprotease-12 as a New target for Cancer Treatment
Proteases and Their Role in Drug Development with an Emphasis in Cancer.-Part C: Proteases and Cardiovascular Defects.-Role of Matrix Metalloproteinases in Atherosclerosis.-The Importance of the Urokinase-type Plasminogen Activator (uPA) and its receptor (uPAR) for the Development and Progression of Atherosclerosis.-Matrix Metalloproteinases and Hypertension.-Regulation of Proteolysis in Vascular Remodeling.-Emerging Role of Genetic Variants of Matrix Metalloproteinases Genes in Left Ventricular Dysfunction.-Implications of Intracellular Proteolytic Activation of MMP-2 in the Heart.-Matrix Metalloprotease-2 in the Development and Progression of Cardiovascular Diseases.-Role of Protease Activation in Subcellular Remodeling and Heart Failure.-Proteases as Potential Targets in Left Ventricular Remodeling After Myocardial Infarction.-MMPs in Cardiovascular Diseases: Emerging Pharmacological Targets.-Proteases as Clinical Markers of Adverse Remodeling for Heart Failure in the Aging Population.

Browse Subjects

Show more subjects...

Statistics

from
to
Export